Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.24 USD | +0.37% | -5.89% | -43.27% |
04-29 | Truist Securities Cuts Teladoc's Price Target to $15 From $17, Maintains Hold Rating | MT |
04-26 | UBS Adjusts Teladoc Price Target to $16 From $20, Maintains Neutral Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.27% | 2.07B | |
+45.73% | 2.61B | |
+115.18% | 703M | |
+8.66% | 451M | |
-65.48% | 154M |
- Stock Market
- Equities
- TDOC Stock
- News Teladoc Health, Inc.
- Barclays Trims Price Target on Teladoc to $25 From $26, Maintains Overweight Rating